16 Results

People

  1. Berger
    Berger
  2. Burman
    Burman
  3. Dickler
    Dickler
  4. Fuks
    Fuks
  5. Hudis
    Hudis
  6. Leibel
    Leibel
  7. Ling
    Ling
  8. LoSasso
    LoSasso
  9. Mageras
    Mageras
  10. Romesser
    Romesser

Groups

  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Survivorship Research (6)
  4. GSK Faculty (5)
  5. Genitourinary Oncology Service (4)
  6. Radiation Oncology, Department of (4)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  8. Breast Medicine Service (3)
  9. Department of Pathology and Laboratory Medicine (3)
  10. Epidemiology and Biostatistics (3)
  1. "dose-escalation"
Formats
  1. Journal Article (11)
  2. Book Section (2)
  3. Review (2)
  4. Meeting Abstract (1)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Survivorship Research (6)
  4. GSK Faculty (5)
  5. Genitourinary Oncology Service (4)
  6. Radiation Oncology, Department of (4)

More Groups

People
  1. C Ling (2)
  2. Chandra Burman (2)
  3. Clifford Hudis (2)
  4. David Solit (2)
  5. Ellen Yorke (2)
  6. Gikas Mageras (2)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2020 (2)
  5. 2018 (2)
  6. 2016 (2)

More Years

Publications
  1. Clinical Cancer Research (2)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. American Journal of Hematology/Oncology (1)
  4. Annual Review of Cancer Biology (1)
  5. Cancer (1)
  6. Cancer Treatment Reviews (1)

More Publications

Publishers
  1. Elsevier Inc. (4)
  2. American Association for Cancer Research (2)
  3. Nature Publishing Group (2)
  4. American Society of Clinical Oncology (1)
  5. Annual Reviews (1)
  6. Demos Medical Publications (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies
    Journal Article

    McKay, R. R.; De Velasco, G.; Werner, L.; Bellmunt, J.; Harshman, L.; Sweeney, C.; Rosenberg, J. E.; Hirsch, M.; Signoretti, S.; Van Allen, E. M.; more...
    Cancer (2016)

    Fulltext@MSK | Save
  • High-risk prostate cancer-classification and therapy
    Journal Article

    Chang, A. J.; Autio, K. A.; Roach, M.; Scher, H. I.
    Nature Reviews Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
    Journal Article

    Liu, M. C.; Demetri, G. D.; Berry, D. A.; Norton, L.; Broadwater, G.; Robert, N. J.; Duggan, D.; Hayes, D. F.; Henderson, I. C.; Lyss, A.; more...
    Cancer Treatment Reviews (2008)

    Fulltext@MSK | Save
  • Intensity-modulated radiotherapy
    Journal Article

    Leibel, S. A.; Fuks, Z.; Zelefsky, M. J.; Wolden, S. L.; Rosenzweig, K. E.; Alektiar, K. M.; Hunt, M. A.; Yorke, E. D.; Hong, L. X.; Amols, H. I.; more...
    The Cancer Journal (2002)

    Fulltext@MSK | Save
  • Reproducibility of organ position with respiratory gating for liver tumors: Use in dose-escalation
    Meeting Abstract

    Wagman, R.; Yorke, E.; Giraud, P.; Ford, E.; Sidhu, K.; Mageras, G.; Minsky, B.; Rosenzweig, K.
    International Journal of Radiation Oncology, Biology, Physics (2001)

    Fulltext@MSK | Save
  • Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study
    Journal Article

    Leibel, S. A.; Heimann, R.; Kutcher, G. J.; Zelefsky, M. J.; Burman, C. M.; Melian, E.; Orazem, J. P.; Mohan, R.; LoSasso, T. J.; Lo, Y. C.; more...
    International Journal of Radiation Oncology, Biology, Physics (1994)

    Fulltext@MSK | Save